Anti-allergy medicine EpiPen recall expands to US
- Author: Ronnie Bowen Apr 02, 2017,
Apr 02, 2017, 1:16
The Food and Drug Administration has issued a recall of 13 lots of EpiPen and EpiPen Jr. due to a potential defect. Both reports are related to the single lot that was previously recalled.
The problems could be potentially life-threatening, although Mylan described the incidence of the defects as 'extremely rare'. The two reports came from a single lot that was previously recalled, Mylan said, but the company was expanding the recall to 13 USA lots distributed in the US between December 2015 and July 2016 as a "precautionary measure out of an abundance of caution".
The widening recall is yet another setback for Mylan in its quest to maintain EpiPen as a big-selling product.
The company says that in total, more than 100,000 products that could be affected were distributed in Canada.
Mylan said it will replace recalled devices free of charge. Mylan also sells a generic version of EpiPen for $300.
Amazon Delays Opening of 'Go' Store
Those kinds of stores would dramatically widen Amazon's real-life retail presence, which is now limited to groceries and books. At an Amazon Go convenience store in Seattle, items are automatically scanned so shoppers can skip the checkout.
It is important that patients continue to carry their current EpiPen Auto-Injector until they receive a replacement device.
To return the product, customers can contact Stericycle at 877-650-3494.
Replacement EpiPens can be obtained from your pharmacy, if it has the auto-injector (or its generic equivalent) in stock. However, the recall is being conducted in Canada out of an abundance of caution.
EpiPen (epinephrine) Auto‐Injectors are indicated for the emergency treatment of anaphylactic reactions in patients who are determined by a physician to be at increased risk for anaphylaxis.